Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA

    Patrizia Tosi, Manuela Imola, Mianulli Anna Maria, Simona Tomassetti, Anna Merli, Annalia Molinari, Serena Mangianti, Marina Ratta, Alessandro Isidori, Giuseppe Visani
    e2012069
    2012-11-05
    https://doi.org/10.4084/mjhid.2012.069
    2731
    PDF: 819
    HTML: 1662
  • OUTLINE OF IRON METABOLISM, WITH EMPHASIS TO ERYTHROID CELLS iron Metabolism

    Ugo Testa, Elvira Pelosi, Germana Castelli
    e2025067
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.067
    2611
    PDF: 1475
    Html: 1144
  • EXTRAMEDULLARY INVOLVEMENT IN ACUTE MYELOID LEUKEMIA. A SINGLE CENTER TEN YEARS EXPERIENCE

    Luana Fianchi, Martina Quattrone, Marianna Criscuolo, Silvia Bellesi, Giulia Dragonetti, Alessio Maria Edoardo Maraglino, Matteo Bonanni, Patrizia Chiusolo, Simona Sica, Livio Pagano
    Page e2021030
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.030
    2694
    PDF: 1002
    HTML: 459
  • MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)

    Ibrahim C. Haznedaroglu
    e2014009
    2013-12-31
    https://doi.org/10.4084/mjhid.2014.009
    4253
    PDF: 1675
    HTML: 9334
    Untitled: 363
    Untitled: 239
    Untitled: 228
    Untitled: 245
    Untitled: 237
    Untitled: 408
  • TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin

    Cristina Papayannidis, Vincenzo Federico, Luana Fianchi, Patrizia Pregno, Novella Pugliese, Alessandra Romano, Federica Irene Grifoni
    e2022073
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.073
    1491
    PDF: 1151
    HTML: 493
  • Multiple bone and joint disease in a sickle cell anaemia patient: a case report

    John Ayodele Olaniyi, Adekunle E Alagbe, Olutoogun O Toluwalase, Olorunsogo E Busari
    e2012023
    2012-05-03
    https://doi.org/10.4084/mjhid.2012.023
    1421
    PDF: 831
    HTML: 1781
  • THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE

    Lucrezia Laterza, Gianenrico Rizzatti, Eleonora Gaetani, Patrizia Chiusolo, Antonio Gasbarrini
    e2016025
    2016-05-01
    https://doi.org/10.4084/mjhid.2016.025
    6594
    PDF: 2287
    HTML: 14185
    Untitled: 268
    figure: 243
  • GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA

    Pouyan Kheirkhah, Ana M. Avila-Rodriguez, Bartlomiej Radzik, Carlos Murga-Zamalloa
    e2021067
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.067
    1996
    PDF: 733
    HTML: 383
  • PREVENTION AND TREATMENT OF HEPATITIS VIRUS INFECTION IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS

    Suparno Chakrabarti, Somnath Mukherjee
    e2009017
    2009-12-10
    https://doi.org/10.4084/mjhid.2009.017
    979
    PDF: 614
    HTML: 2490
  • IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?

    Federica Sorà, Patrizia Chiusolo, Francesco autore, Sabrina Giammarco, luca laurenti, elisabetta metafuni, idanna innocenti, eugenio galli, andrea bacigalupo, simona sica
    e2021062
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.062
    1434
    PDF: 600
    HTML: 227
  • Multiple myeloma diagnosed by CT-guided rib biopsy after a hemodilute bone marrow aspirate, in a patient with a biclonal pattern on serum protein electrophoresis Multiple Myeloma diagnosed with CT-guided rib biopsy

    Arjeta Cyrbja, Liri Seraj, Shaqir Qerama
    e2026061
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.061
    308
    PDF: 168
    HTML: 285
  • TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi
    e2023038
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.038
    2532
    PDF: 1959
    HTML: 1097
  • Common parasite with uncommon associations

    Sonal Jain, Jasmita Dass, Monica Sharma, Seema Tyagi
    e2011015
    2011-03-29
    https://doi.org/10.4084/mjhid.2011.015
    1625
    PDF: 769
    HTML: 1877
  • EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES

    Pietro Tralongo, Arianna Bakacs, Luigi Maria Larocca
    e2024042
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.042
    4753
    PDF: 1837
    HTML: 1424
  • AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS

    Pavankumar Tandra, Jairam Krishnamurthy, Vijaya Bhatt, Kam Newman, James O Armitage, Mojtaba Akhtari
    e2013068
    2013-11-04
    https://doi.org/10.4084/mjhid.2013.068
    2586
    PDF: 1305
    HTML: 3924
  • IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?

    Giuseppe Gritti, Chiara Pavoni, Alessandro Rambaldi
    e2017010
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.010
    3689
    PDF: 1391
    HTML: 2428
    Fi.1 Gritti.Rambaldi: 278
  • Morphologic confounders and CD19 negativity in a case of hairy cell leukemia.

    Pulkit Rastogi, Sreejesh Sreedharanunni, Uday Yanamandra, Man Updesh Singh Sachdeva, Neelam Varma
    e2017033
    2017-05-01
    https://doi.org/10.4084/mjhid.2017.033
    2425
    PDF: 986
    HTML: 1271
  • TYROSINE KINASE INHIBITORS AND INTERFERON

    Maria Dimou, Panagiotis Panagiotidis
    e2014006
    2014-01-02
    https://doi.org/10.4084/mjhid.2014.006
    3069
    PDF: 1551
    HTML: 3107
    Cover Letter: 284
  • Concurrent diagnosis of acute myeloid leukemia and symptomatic COVID-19 infection: a case report successfully treated with Azacitidine-Venetoclax combination

    Daniela Taurino, Marco Frigeni, Anna Grassi, Gianluca Cavallaro, Silvia Salmoiraghi, Orietta Spinelli, Alessandro Rambaldi, Federico Lussana
    e2021057
    2021-08-28
    https://doi.org/10.4084/MJHID.2021.057
    1485
    PDF: 603
    HTML: 232
  • GENE THERAPY IN THALASSEMIA AND HEMOGLOBINOPATHIES

    Laura Breda, Roberto Gambari, Stefano Rivella
    e2009008
    2009-11-16
    1448
    PDF: 477
    HTML: 3172
  • ATRA induced Reactive Hemophagocytosis: A Case Report

    Monica Sharma, Sanjeev Kumar Sharma, Jasmita Dass, Seema Tyagi
    e2011034
    2011-09-08
    https://doi.org/10.4084/mjhid.2011.034
    1338
    PDF: 677
    HTML: 2933
    ATRA induced Reactive Hemophagocytosis: A Case Report: 262
  • PROGNOSTIC IMPACT OF IMMUNOHISTOCHEMICAL P53 EXPRESSION IN BONE MARROW BIOPSY IN HIGHER RISK MDS: A PILOT STUDY

    Alfredo Molteni, Emanuele Ravano, Marta Riva, Michele Nichelatti, Laura Bandiera, Lara Crucitti, Mauro Truini, Roberto Cairoli
    e2019015
    2019-02-26
    https://doi.org/10.4084/mjhid.2019.015
    2029
    PDF: 1063
    HTML: 368
  • FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.

    Andrea Gallamini, Anna Borra
    e2017029
    2017-04-15
    https://doi.org/10.4084/mjhid.2017.029
    3479
    PDF: 1380
    HTML: 2380
  • THROMBOCYTOPENIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - STILL AN UNSOLVED PROBLEM

    May Basood, Howard S. Oster, Moshe Mittelman
    e2018046
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.046
    3427
    PDF: 1502
    HTML: 755
  • Long-term persistence of dysplastic features in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide

    Enrico Santinelli, Maria Rosaria Pascale, Luca Guarnera, Arianna Savi, Flavia Mallegni, Carmelo Gurnari, Luca Maurillo, Maria Teresa Voso, Susanna Fenu
    e2025038
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.038
    1213
    PDF: 828
    HTML: 152
  • BENDAMUSTINE AND RITUXIMAB AS FIRST LINE TREATMENT IN SPLENIC MARGINAL ZONE LYMPHOMAS of ELDERLY PATIENTS.

    Roberto Castelli
    e2016030
    2016-07-01
    https://doi.org/10.4084/mjhid.2016.030
    6240
    PDF: 1063
    HTML: 2379
  • HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS

    Mazyar Shadman, Joachim Deeg
    e2014056
    2014-09-01
    https://doi.org/10.4084/mjhid.2014.056
    2276
    PDF: 864
    HTML: 3294
  • Community-acquired Carbapenem-resistant Escherichia coli Bacteremia Complicated by c: A Case Report

    Yu Chen, Jin Zhang, wenqiang kong
    e2026005
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.005
    688
    PDF: 535
    HTML: 165
  • ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA

    Luca Laurenti, Michela Tarnani, Patrizia Chiusolo, Federica Sorà, Simona Sica
    e2010026
    2010-08-31
    https://doi.org/10.4084/mjhid.2010.026
    1552
    PDF: 891
    HTML: 1046
  • HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation

    Anna Maria Testi
    e2022038
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.038
    1467
    PDF: 944
    HTML: 284
  • ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES

    Daniel Olson, Abraham Tareq Yacoub, Gelenis Domingo, John Norman Greene
    e2014068
    2014-08-28
    https://doi.org/10.4084/mjhid.2014.068
    2522
    PDF: 823
    HTML: 2160
    Untitled: 308
    Untitled: 205
    Untitled: 246
    Untitled: 221
    Untitled: 246
    Untitled: 258
    Untitled: 253
  • Fatal disseminated fusariosis during induction therapy for adult acute lymphoblastic leukemia in a patient with prior multiple myeloma

    Sara Alberti, Gianluca Cavallaro, Alessandra Tebaldi, Paola Tebaldi, Maria Chiara Finazzi, Anna Grassi, Monica Galli, Laura Paris, Paola Stefanoni, Francesca Valsecchi, Alessandro Rambaldi, Federico Lussana
    e2026074
    2026-09-01
    https://doi.org/10.4084/MJHID.2026.074
    203
    PDF: 156
    Html: 60
  • RECENT ADVANCES IN THE 5Q- SYNDROME

    Andrea Pellagatti, Jacqueline Boultwood
    e2015037
    2015-05-20
    https://doi.org/10.4084/mjhid.2015.037
    3205
    PDF: 1979
    HTML: 3859
    Pellagatti Fig 1: 285
    Pellagatti Fig. 2: 268
  • USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS

    Paola Mancino, Katia Falasca, Claudio Ucciferri, Eligio Pizzigallo, Jacopo Vecchiet
    e2010003
    2010-03-26
    https://doi.org/10.4084/mjhid.2010.003
    1367
    PDF: 609
    HTML: 984
  • CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment

    Michele Malagola, Raffaella Greco, Stella Santarone, Anna Paola Iori, Luisa Quatrocchi, Walter Barberi, Bruzzese Antonella, Salvatore Leotta, Alessandra Carotti, Antonio Pierini, Simon Bernardi, Enrico Morello, Nicola Polverelli, Alessandro Turra, Federica Cattina, Lisa Gandolfi, Benedetta Rambaldi, Francesca Lorentino, Francesca Serio, Annalisa Natale, Giuseppe Milone, Andrea Velardi, Robin Foà, Fabio Ciceri, Domenico Russo, Jacopo Peccatori
    e2019048
    2019-08-29
    https://doi.org/10.4084/mjhid.2019.048
    2833
    PDF: 1284
    HTML: 297
  • TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.

    Aditi Singh, MD, Ishaq Asghar, MD, Laura Kohler, DO, Hosam Hakim, MD, Daniel Snower, MD, Daniel Lebovic, MD
    e2022018
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.018
    2155
    PDF: 889
    HTML: 689
  • CURRENT STRATEGIES FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

    Juliana Maria Camargos Rocha, Sandra Guerra Xavier, Marcelo Eduardo Lima Souza, Juliana Godoy Assumpção, Mitiko Murao, Benigna Maria Oliveira
    e2016024
    2016-04-10
    https://doi.org/10.4084/mjhid.2016.024
    4886
    PDF: 1438
    HTML: 4989
  • CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE

    omar ziad alrawi, fawzi abdel-latif abdel-rahman, rula alnajjar, husam abujazar, mourad salam, mustafa saad
    e2015049
    2015-08-25
    https://doi.org/10.4084/mjhid.2015.049
    1655
    PDF: 1003
    HTML: 1036
    figures: 246
    table 1: 255
    table2: 252
    table3: 258
  • A case of severe gastrointestinal toxicity after allogeneic hematopoietic stem cell transplantation: can we improve the evaluation of the “gut fitness“ ?

    Gabriele Magliano, Enrico Morello, Mirko Farina, Vera Radici, Marco Galli, giulia brambilla, Michele Malagola, Domenico Russo, Daniele Avenoso
    e2025054
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.054
    825
    PDF: 683
    HTML: 173
  • INFECTIONS IN THALASSEMIA AND HEMOGLOBINOPATHIES

    Bianca Maria Ricerca, Arturo Di Girolamo, Deborah Rund
    e2009028
    2009-12-28
    1505
    PDF: 746
    HTML: 4479
  • Acute Hemolytic Anemia Following Rasburicase in a Very Late Post-Transplant Relapse of Acute Myeloid Leukemia

    Gianluca Cavallaro, Federico Lussana, Marco Frigeni, Maria Caterina Micò, Alessandra Algarotti, Anna Grassi, Orietta Spinelli, Chiara Pavoni, Elena Oldani, Alessandro Rambaldi
    e2026003
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.003
    745
    PDF: 626
    Html: 267
  • ACTIVIN RECEPTOR LIGAND FOR THR TREATMENT OF BETA-THALASSEMIA: a SERENDIPITOUS DISCOVERY

    Irene Motta, Valentina Brancaleoni, Isabella Nava, Paola Delbini, Lorena Duca
    e2020075
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.075
    1817
    PDF: 1538
    HTML: 666
  • ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN THE TREATMENT OF CHRONIC LYMPHOCITIC LEUKEMIA : WHY AND WHEN ?

    Maria L. Delioukina, Stephen J. Forman
    e2010018
    2010-06-30
    https://doi.org/10.4084/mjhid.2010.018
    1384
    PDF: 860
    HTML: 640
  • OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWING REDUCED-INTENSITY CONDITIONINIG REGIMEN IN PATIENTS WITH IDIOPATHIC MYELOFIBROSIS: THE G.I.T.M.O. EXPERIENCE AND REVIEW OF THE LITERATURE

    Francesca Patriarca, Andrea Bacigalupo, Alessandra Sperotto, Miriam Isola, Maria Teresa Van Lint, Anna Paola Iori, Paolo Di Bartolomeo, Maurizio Musso, Pietro Pioltelli, Giuseppe Visani, Pasquale Iacopino, Renato Fanin, Alberto Bosi
    e2010010
    2010-05-07
    https://doi.org/10.4084/mjhid.2010.010
    1647
    PDF: 868
    HTML: 785
  • Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review

    Susmitha Apuri, Kristin Carlin, Edward Bass, Phuong Thuy Nguyen, John Norman Greene
    e2014014
    2014-02-18
    https://doi.org/10.4084/mjhid.2014.014
    3776
    PDF: 1661
    HTML: 4576
    CoverLetter: 305
    Figure1: 319
  • Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy

    Antonella Vaccarino, Irene Dogliotti, Fabio Marletto, Andrea Demarchi, Mario Bazzan
    e2016050
    2016-10-20
    https://doi.org/10.4084/mjhid.2016.050
    2994
    PDF: 839
    HTML: 1342
    Blood Count trend before and during lenalidomide treatment: 254
    Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 250
  • ROLE OF BIOMARKERS AS PREDICTORS OF INFECTION AND DEATH IN NEUTROPENIC FEBRILE PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION.

    Karim Massaro, Silvia F Costa
    e2015059
    2015-10-15
    https://doi.org/10.4084/mjhid.2015.059
    2331
    PDF: 1099
    HTML: 1828
  • Clinical and Prognostic Features in a Young Adult Patient with de novo Myelodysplastic Syndrome presenting t(11;16) (q23; q24)

    Viviane Lamim Lovatel, Luize Otero, Ercole Pietro Orlando, Claudia Diniz, Filipe Vicente dos Santos-Bueno, Bruno Almeida Lopes, Elaiza Almeida Antônio de Kós, Monica Kopischitz Praxedes Lusis, Eliana Abdelhay, Teresa de Souza Fernandez
    e2022013
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.013
    1305
    PDF: 659
    HTML: 255
  • CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA

    Livio Pagano, Morena Caira, Caterina Giovanna Valentini, Luana Fianchi
    e2009030
    https://doi.org/10.4084/mjhid.2009.030
    1510
    PDF: 667
    HTML: 4208
  • THALASSAEMIA INTERMEDIA : AN UPDATE

    Ali Taher, Khaled M. Musallam, Maria Domenica Cappellini
    e2009004
    2009-08-17
    1179
    PDF: 496
    HTML: 9496
101 - 150 of 452 items << < 1 2 3 4 5 6 7 8 9 10 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.